Infectious Disease Control

6 Interesting Places in the Philippines Worth Seeing After Pandemic

MANILA, Philippines, Aug. 31, 2021 /PRNewswire/ -- In preparation to ensure safe travels for future visitors of the country, under the direction of the Philippine Secretary of Tourism,Berna Romulo-Puyat, the Department of Tourism (DOT) has actively implemented new public health and safety guideli...

2021-08-31 19:33 343

Organ transplants fell by a third worldwide during first wave of COVID-19 pandemic, new study presented at ESOT Congress 2021 shows

MILAN, Aug. 31, 2021 /PRNewswire/ -- The number of solid organ transplants performed during the first wave of COVID-19 in 2020 plunged by 31% compared to the previous year, according to a new global study presented at theEuropean Society for Organ Transplantation (ESOT) Congress 2021

2021-08-31 07:01 1957

Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test

HONG KONG, Aug. 30, 2021 /PRNewswire/ -- PHASE Scientific announces that its  INDICAID™ COVID-19 Rapid Antigen Test (INDICAID™) has received Emergency Use Authorization from the Ministry of Health (MOH) of the Republic ofKenya on 17 August 2021. The authorization enables the test to be used in Ken...

2021-08-30 09:00 3878

INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800

INOVIO's global Phase 3 efficacy trial receives authorization to proceed from Brazil; other countries to follow INOVIO to conduct INNOVATE Phase 3 efficacy trial with partner Advaccine in areas of world in need of COVID-19 vaccines PLYMOUTH MEETING, Pa., Aug. 26, 2021 /PRNewswire/ -- INOVIO (NAS...

2021-08-26 20:00 2946

RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant

TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced preliminary results of a new preclinical study showing strong inhibiti...

2021-08-26 19:50 3030

XABT Donates 2019-nCoV Nucleic Acid Detection Kits to Vientiane, Laos

BEIJING, Aug. 25, 2021 /PRNewswire/ -- Atsaphangthong Siphandone, Mayor of Vientiane, the capital of Laos, recently issued an honorary certificate to Beijing Applied Biological Technologies (XABT) for the donation of 2019-nCoV Nucleic Acid Detection Kits to supportVientiane's efforts at epidemic ...

2021-08-25 22:06 3730

Study Confirms Viraleze Antiviral Nasal Spray Provides Protection Against SARS-CoV-2 in Challenge Model

MELBOURNE, Australia, Aug. 23, 2021 /PRNewswire/ -- Melbourne biotech company Starpharma has announced the publication of new data demonstrating the capability of its Viraleze antiviral nasal spray to protect against SARS-CoV-2 in an animal challenge model of SARS-CoV-2 infection[1]. Viraleze adm...

2021-08-23 20:23 4014

Shielding Our Singapore Spirit: Mamoru Marketing Shields More Than 12,000 NDP 2021 Participants with Clinical Grade ECOM products

SINGAPORE, Aug. 19, 2021 /PRNewswire/ -- Celebrating Singapore's 56th year of independence, Mamoru Marketing Pte Ltd, exclusive distributor for ECOM products inSingapore, is proud to partner with the National Day Parade (NDP) 2021 for the first time this year to lend a hand in ensuring a COVID-Sa...

2021-08-19 20:47 3245

COVID-19 CARE Assist & Employer Tracking Programme Launched by DoctorOnCall

KUALA LUMPUR, Malaysia, Aug. 18, 2021 /PRNewswire/ -- DoctorOnCall, Malaysia's first and largest digital health platform today announced the launch of the DoctorOnCall Covid-19 CARE Assist programme for all purchasers of the Rapid Antigen (RTK-Ag) Self-Test kits. This benefit is available to A...

2021-08-18 10:00 2777

InferVision AI Assists the European Commission Monitoring COVID-19 Variants

WIESBADEN, Germany, Aug. 16, 2021 /PRNewswire/ -- InferVision AI has been selected to help monitor COVID-19 variants across the European Union. Faced with this challenge, the European Commission decided to increase their investment in the adoption of AI tools from InferVision. InferVision's AI to...

2021-08-16 21:51 3326

Ping An Supports COVID-19 Control Efforts in Philippines

HONG KONG and SHANGHAI, Aug. 16, 2021 /PRNewswire/ -- COVID-19 diagnosis and treatment inthe Philippines is being supported by Ping An's groundbreaking artificial intelligence-driven AskBob Clinical Decision Support System, announced Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Pin...

2021-08-16 17:22 9944

Introducing ProXmask(TM): Antiviral Face Mask as Better Alternative to Double-Masking and Capable of Inactivate SARS-CoV-2

KUALA LUMPUR, Malaysia, Aug. 16, 2021 /PRNewswire/ -- ProXmask™ is the first antiviral face mask mass-produced in theAsia Pacific by Prolexus Group. The antiviral face mask created by Prolexus Group is a remarkable example of conventional OEM (original equipment manufacturer) for globally renowne...

2021-08-16 15:21 2636

Regent Taipei Prioritizes Your Wellbeing

TAIPEI, Aug. 13, 2021 /PRNewswire/ -- As Taiwan lifts restrictions and indoor dining resumes inTaipei and New Taipei City, Regent Taipei has collaborated with LEDTECH Electronics Corporation, a world-renowned semiconductor lighting company, to enhance the hotel's epidemic preventative measures an...

2021-08-13 16:51 2676

F&NHB Achieves 100% Vaccination Rate of its Workforce in Klang Valley, Bentong and East Malaysia, 90% Nationwide

KUALA LUMPUR, Malaysia, Aug. 11, 2021 /PRNewswire/ -- Over 1,000 employees, contractors, and suppliers of Fraser & Neave Holdings Bhd (F&NHB or the Group) and its associated companies have received two doses of COVID-19 vaccination as part of the F&N-PIKAS Programme (Program Imunisasi Industri CO...

2021-08-11 12:31 2215

INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration

HONG KONG and GARDEN GROVE, Calif., Aug. 11, 2021 /PRNewswire/ -- PHASE Scientific International LTD (PHASE Scientific), today announced that itsINDICAID™ COVID-19 Rapid Antigen Test (INDICAID) received Emergency Use Authorization (EUA) from the U.S. Food and D...

2021-08-11 01:00 3156

Prenetics and New World Development Launch Circle HealthPod, the World's Most Advanced At-Home Covid-19 test

* Circle HealthPod is a Rapid Detection System for all infectious diseases, starting with Covid-19 and will include Flu and STDs in the future * Technology developed at University of Oxford, with PCR quality results in 20 minutes * Circle HealthPod, having received CE-IVD marking, is a reusa...

2021-08-10 07:00 4774

Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination

* Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series * Six-fold increase in cross-reactive functional antibodies to Delta variant compared to primary vaccination series * Analysis of sera from primary ...

2021-08-06 05:03 8605

Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine

- Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General ofIndia and to regulatory agencies in Indonesia and Philippines for Novavax' recombinant nanoparticle COVID-19 vaccine - Filing for World Health Organization Emergency Use Listing expected in Augus...

2021-08-06 04:41 8026

Ortho Clinical Diagnostics Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocapsid Antibody Test

 -- Ortho's new VITROS® Anti-SARS-CoV-2 Total N test detects the individual's immune response to the COVID-19 virus and is intended to help clinicians understand if their patient had a recent or prior COVID-19 infection.  -- Ortho is the first company to have an EUA for both a quantitative IgG a...

2021-08-05 21:05 28323

Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine

GAITHERSBURG, Md., Aug. 4, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has reached an agreement with the European Commission (EC) for the purchase of up to 200 million doses...

2021-08-04 21:10 9107
1 ... 20212223242526 ... 66